Overall rank by patents
#3,356
Across all tracked assignees
USPTO PatentsView assignee record - 111 granted patents across 19 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
The verdict
ROM holds 111 US patents across 19 technology areas, rank #3,356 of 50,000 tracked assignees.
ROM Technologies, Inc. has been granted 111 US utility patents between 2020 and 2025, placing ROM Technologies, Inc. at rank #3,356 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.2 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, ROM Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, ROM sits between MUSC Foundation For Research Development (111 patents, rank #3,352) and Seco Tools AB (111 patents, rank #3,360) - the closest US assignees by grant volume. The composite Innovation Score of 64.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 111 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. ROM Technologies, Inc.'s 21.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ROM Technologies, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MUSC Foundation for Research Development
111 patents
MillerKnoll, Inc.
111 patents
NeuroPace, Inc.
111 patents
PTC THERAPEUTICS, INC.
111 patents
S.V.V. TECHNOLOGY INNOVATIONS, INC.
111 patents
SAGEMCOM ENERGY & TELECOM SAS
111 patents
SCA IPLA HOLDINGS INC.
111 patents
Seco Tools AB
111 patents
ROM Technologies, Inc.
111 patents
What this shows ROM holds 111 patents at rank #3,356, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,356 in granted patent volume.
Other assignees with the most granted patents in ROM's primary technology class.
ROM's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
64 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 0.9% |
| 2021 | 11 | 9.9% |
| 2022 | 23 | 20.7% |
| 2023 | 7 | 6.3% |
| 2024 | 33 | 29.7% |
| 2025 | 36 | 32.4% |
Top 15 of 19 technology areas
Overall rank by patents
#3,356
Across all tracked assignees
64.4 out of 100
How to use this portfolio
ROM's 111 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.